BSEMediumNeutral
Announced Fri, 2 May · 21:33 IST
As per attachment
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Ms. Sukanya Choudhury, Executive Vice President - Regulatory Affairs, has been moved to a 16-month secondment role as Regulatory Head for GSK's Growth Emerging Markets, effective 1st May 2025. As a result of this secondment, she ceases to be a Senior Management Personnel (SMP) of the Indian listed company. This is an internal group transfer within the broader GSK organisation rather than an exit from the company.
Likely market impact
No material negative impact expected — this is an internal secondment within the GSK group, not an outright resignation, so her expertise is retained within the parent organisation. Investors should view it as routine senior management reshuffling within a multinational structure.